Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,146 public trials 1,872 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT03184571

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +14 more
Locations
  • Dartmouth-Hitchcock Medical Center (DHMC) Lebanon, New Hampshire, United States
  • Medical College of Wisconsin, 9200 W Wisconsin Avenue Milwaukee, Wisconsin, United States
  • Radiumhospitalet, Oslo University Hospital PB Oslo, Norway
  • Hospital Universitari Germans Trias i Pujol-ICO Barcelona, Badalona, Spain
View all 13 locations
View Trial Details
Completed

Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy

NCT02514447

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Compassionate Cancer Care Medical Group, Inc. Corona, California, United States
  • Sutter Medical Group Sacramento, California, United States
View all 50 locations
View Trial Details
Completed

Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC

NCT03041311

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • Loma Linda University Loma Linda, California, United States
  • UCLA Medical Center - Santa Monica Hematology And Oncology Santa Monica, California, United States
View all 45 locations
View Trial Details
Completed

Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial

NCT03801902

Conditions
Locally Advanced Lung Non-Small Cell Carcinoma, Locally Recurrent Lung Non-Small Cell Carcinoma, Lung Diseases, +9 more
Locations
  • Grady Health System Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View all 56 locations
View Trial Details

Related conditions